|
|||||
|
|
The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study |
|
| Authors: | Lamy Andre Wang Xiaoyin Gao Peggy Tong Wesley Gafni Amiram Dans Antonio Avezum Alvaro Ferreira Rafael Young James Yusuf Salim Teo Koon;ONTARGET Investigators |
| Institution: | CADENCE Research Group, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada. lamya@mcmaster.ca |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |